ISPOR 2022
May 15-18, 2022
ISPOR 2022 News Center
Explore the news and reporting from ISPOR 2022 in the News Center with curated stories on cutting-edge topics from the conference.
ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems
The Patient (Finally) at the Center: How Can We Leverage Digital Data to Make Patient-Focused Decisions?
Patients are increasingly at the center of healthcare decision making. Digital health has been crucial for leveraging patient-centric data, however, also introduces concerns with regards to patient privacy and data protection. The focus of this plenary session was making the best use of digital health data while maintaining patient data protection and privacy.
2022/05/23 | Value & Outcomes Spotlight
Trial Emulation With Real-World Data: Evidence on Feasibility, Challenges, and Opportunities
2022/05/23 | Value & Outcomes Spotlight
HTA for Gene Therapies: Are Our Methods Fit for Purpose?
2022/05/23 | Value & Outcomes Spotlight
Computable Phenotypes for Generating RWE: What Are They and Can They Really Be Standardized and Reused?
2022/05/23 | Value & Outcomes Spotlight
Using Big Data to Unpack the Health Equity Considerations
2022/05/18 | Value & Outcomes Spotlight
Can Pharmaceutical Pricing Move Beyond Cost QALY for Value Consideration?
2022/05/18 | Value & Outcomes Spotlight
Advances in the Development of Real-World Evidence
2022/05/18 | Value & Outcomes Spotlight
Machine Learning in HEOR: Are We at the Final Frontier?
2022/05/18 | Value & Outcomes Spotlight
Opening Day Plenary Features Discussion on HTA on the Run
2022/05/18 | Value & Outcomes Spotlight
Capturing Humanistic Outcomes: A Vital Part of Therapeutic Management
2022/05/16 | ISPOR's Value & Outcomes Spotlight
Examining the Cost-Effectiveness in Oncology Studies
2022/05/16 | ISPOR's Value & Outcomes Spotlight
Analytic Studies in Patient-Centered Research
2022/05/16 | ISPOR's Value & Outcomes Spotlight
Applying Disparate Data Sources and Methods for Evaluating Real-World Evidence
2022/05/16 | ISPOR's Value & Outcomes Spotlight
The ISPOR 2022 conference theme—The Future of HEOR in Patient-Driven Digital Healthcare Systems—is a “green thread” that is woven throughout many conference sessions to bring a fresh and holistic view into the future of HEOR in patient-driven digital healthcare systems.
Plenary Sessions
Plenary 3: The Patient (Finally) at the Center: How Can We Leverage Digital Data to Make Patient-Focused Decisions? [Value & Outcomes Spotlight]
Plenary 2: Using Big Data to Unpack the Health Equity Considerations [Value & Outcomes Spotlight]
Plenary 1: Opening Day Plenary Features Discussion on HTA on the Run [Value & Outcomes Spotlight]
Real-World Evidence
Video: ISPOR Introduces RWE Subprogram [Value & Outcomes Spotlight]
Trial Emulation With Real-World Data: Evidence on Feasibility, Challenges, and Opportunities [Value & Outcomes Spotlight]
Computable Phenotypes for Generating RWE: What Are They and Can They Really Be Standardized and Reused? [Value & Outcomes Spotlight]
Advances in the Development of Real-World Evidence [Value & Outcomes Spotlight]
Applying Disparate Data Sources and Methods for Evaluating Real-World Evidence [Value & Outcomes Spotlight]
Use of Real-World Evidence to Assess Comparative Effectiveness, Safety, and Medication Adherence [Value & Outcomes Spotlight]
Health Technology Assessment
HTA for Gene Therapies: Are Our Methods Fit for Purpose? [Value & Outcomes Spotlight]
Expanding Value Elements in HTA Frameworks: Should We Do It and How Much Should We Weight Them? [Value & Outcomes Spotlight]
Expanding Value Elements in HTA Frameworks: Should We Do It and How Much Should We Weigh Them? [Value & Outcomes Spotlight]
Machine Learning
Machine Learning Methods Session Draw Large Crowds at ISPOR 2022 [Value & Outcomes Spotlight]
Machine Learning in HEOR: Are We at the Final Frontier? [Value & Outcomes Spotlight]
Patient Centric
Analytic Studies in Patient-Centered Research [Value & Outcomes Spotlight]
Are We Patient and Care-Partner Centric Enough in Early Alzheimer’s Disease Clinical Trials? [Value & Outcomes Spotlight]
What Treatment Attributes Do Patients Value? Using Discrete Choice Experiments to Understand the Complex Trade-Offs Made by Patients [Value & Outcomes Spotlight]
And More...
ISPOR 2022: Editor’s Picks [The Evidence Base]
Can Pharmaceutical Pricing Move Beyond Cost QALY for Value Consideration? [Value & Outcomes Spotlight]
Emerging Methods in Economic Evaluations [Value & Outcomes Spotlight]
HEOR Studies in Medication Management [Value & Outcomes Spotlight]
Examining the Cost-Effectiveness in Oncology Studies [Value & Outcomes Spotlight]
Capturing Humanistic Outcomes: A Vital Part of Therapeutic Management [Value & Outcomes Spotlight]
An Interview with Grammati Sarri on Moderating an Issue Panel at ISPOR US 2022 [Cytel]
ISPOR 2022 Plenaries and Speakers Announced [ISPOR]
ISPOR 2022 Offering Real-World Evidence Subprogram [ISPOR]
Poster Sessions
Poster Session Recap: Rare and Orphan Diseases [Value & Outcomes Spotlight]
Poster Session Recap: Infectious Disease (Non-Vaccine) [Value & Outcomes Spotlight]
Poster Session Recap: Diabetes/Endocrine/Metabolic Disorders [Value & Outcomes Spotlight]
Poster Session Recap: Mental Health [Value & Outcomes Spotlight]
Poster Session Recap: Low- and Middle-Income Countries [Value & Outcomes Spotlight]
Poster Session Recap: Real-World Evidence Studies [Value & Outcomes Spotlight]
Poster Session Recap: Cardiovascular Disorders [Value & Outcomes Spotlight]
Photo Gallery
Additional News From the Conference
Guardian Research Network and Cytel Announce Presentation at ISPOR 2022 Detailing Covid-19's Impact on Breast Cancer [Guardian Research Network]
Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month [Yahoo! Finance]
Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022 [Pharmaceutical Daily]
Arcadia Partners With Datavant to Accelerate Biopharma Research [PharmaLive]
SYNAPS Dx Presents at ISPOR Annual Conference, Demonstrates 90% of Physicians Follow Results of DISCERN, First Skin Test for Alzheimer’s Disease [The One Observer News Enterprise]
Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events [Pharmaceutical Daily]
AESARA, Inc to Present New Health Economics and Outcomes Research Data at ISPOR 2022 [The AI Journal]
ChemoCentryx Announces Upcoming Conference Abstracts Focused on TAVNEOS (avacopan) and the Burden of Systemic Glucocorticoid Use in ANCA-Associated Vasculitis [Wall Street Online]
OMNY Health Debuts Ophthalmology-Centric Real-World Data Platform [Ophthalmology Times]
Veradigm Presentations at ISPOR 2022 Highlight Broader Access to and Integration of Real-world Data Sources [Yahoo! Finance]
CorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR [Yahoo! Finance]
Pathnostics to Present New Real-World Method to Identify and Evaluate Cost Outcomes of a Novel, Uncoded UTI Diagnostic at ISPOR 2022 [The Daily Journal]
Komodo Health Platform Accelerates Real-World Evidence For Life Sciences [Silicon]
Other News
Thank You to ISPOR 2022 Media Partners:
A special thank you to ISPOR 2022's Media Partner—The Evidence Base—and to all the media outlets who are reporting on the conference.
Disclaimer:
The reporting on ISPOR 2022 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.